Immune Checkpoint inhibitors

Immunology-based therapy is rapidly developing into an effective treatment option for a surprising range of cancers. We have learned over the last decade that powerful immunologic effector cells may be blocked by inhibitory regulatory pathways controlled by specific molecules often called "immune checkpoints." The development of a new therapeutic class of drugs that inhibit these inhibitory pathways has recently emerged as a potent strategy in oncology. Three sets of agents have emerged in clinical trials exploiting this strategy. These agents are antibody-based therapies targeting cytotoxic T-lymphocyte antigen 4 (CTLA4), programmed cell death 1 (PD-1), and programmed cell death ligand 1 (PD-L1). These inhibitors of immune inhibition have demonstrated extensive activity as single agents and in combinations. Clinical responses have been seen in melanoma, renal cell carcinoma, small cell lung cancer, and several other tumor types.

    Related Conference of Immune Checkpoint inhibitors

    May 06-07, 2020

    Bioenergy Meet 2020

    Valencia, Spain
    June 23-24, 2020

    34th World Congress on Vaccines and Immunization

    Osaka, Japan
    June 25-26, 2020

    Global Congress on Asthma, Allergy and Immunology

    Bali, Indonesia
    September 16-17, 2020

    8th World Summit on Allergy and Clinical Immunology

    Barcelona, Spain
    October 12-13, 2020

    35th World Congress on Immunology

    London, UK
    October 12-13, 2020

    International Conference on Vaccine and Vaccine Research

    Manila, Philippines
    October 12-13, 2020

    4th International Conference on Mass Spectrometry

    Milan, Italy
    October 14-15, 2020

    13th International Conference on Allergy & Immunology

    Zurich, Switzerland
    October 19-20, 2020

    2nd World Conference on Vaccine and Immunology

    Helsinki, Finland
    October 26-27, 2020

    13th Global Summit on Immunology and Cell Biology

    Amsterdam, Netherlands
    October 26-27, 2020

    10th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    October 28-29, 2020

    12th Annual Conference on Clinical Immunology

    Dubai, UAE
    October 29-30, 2020

    International Conference on HIV and AIDS

    Cape Town, South Africa
    November 2-3, 2020

    International Conference on Immunology

    Rome, Italy
    November 05-06, 2020

    4th Annual Summit on Rare Diseases and Orphan Drugs

    Paris, France
    November 18-19, 2020

    International Conference on Immunology & Immunotherapies

    Bangkok, Thailand
    June 28-30 2020

    veternarymedicine-2020

    Immune Checkpoint inhibitors Conference Speakers